Coherus Oncology, Inc. (CHRS)
1.71
+0.08
(+4.91%)
USD |
NASDAQ |
Feb 19, 16:00
1.725
+0.02
(+0.88%)
After-Hours: 07:34
Coherus Oncology Profit Margin (Quarterly) : -384.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| CorMedix, Inc. | -- |
| Verastem, Inc. | -876.3% |
| Anavex Life Sciences Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -40.99% |
| Return on Invested Capital | -115.7% |
| Gross Profit Margin (Quarterly) | 59.49% |
| Operating Margin (Quarterly) | -365.0% |
| Return on Net Operating Assets | -116.5% |